A carregar...
Amyloid imaging, risk disclosure and Alzheimer’s disease: ethical and practical issues
PET ligands that bind with high specificity to amyloid plaques represent a major breakthrough in Alzheimer’s disease (AD) research. Amyloid neuroimaging is now approved by the US FDA to aid in the diagnosis of AD, and is being used to identify amyloid-positive but asymptomatic individuals for second...
Na minha lista:
| Publicado no: | Neurodegener Dis Manag |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4498486/ https://ncbi.nlm.nih.gov/pubmed/26167204 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nmt.13.25 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|